Wealth Enhancement Advisory Services’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
Wealth Enhancement Advisory Services's RCKT Position: Q3 2026 in Review
Wealth Enhancement Advisory Services reduced its Rocket Pharmaceuticals (RCKT) stake by 67% in Q3 2026, selling an estimated $211K and leaving 30,588 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3972.
Wealth Enhancement Advisory Services first reported a position in RCKT in Q3 2025 and has held it in 5 quarters since. The position peaked at $358K in Q2 2026. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- Wealth Enhancement Advisory Services held 30,588 shares of Rocket Pharmaceuticals worth $80.4K as of Q3 2026.
- Wealth Enhancement Advisory Services sold 60,980 Rocket Pharmaceuticals shares in Q3 2026, an estimated $211K.
- Rocket Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3972 holding.
- Wealth Enhancement Advisory Services first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Wealth Enhancement Advisory Services's Rocket Pharmaceuticals position peaked at $358K in Q2 2026.
- 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.